Thursday, September 18, 2025
HomeIndustriesHealthcare

Healthcare

StemCyte Announces FDA Approval of IND for a Phase II Clinical Trial

Southern California cord blood regenerative therapeutics company StemCyte is pleased to announce it has received approval from the U.S. Food and Drug Administration (FDA)...

Bactolife Receives Usd 5 Million In New Funding To Address Gastrointestinal Infections

Bactolife announced that the Bill & Melinda Gates Foundation has committed, in alignment with the foundation's charitable mission, an investment of USD 5 million...

Galaxy Medical Receives CE Mark for CENTAURI Pulsed Electric Field System

Galaxy Medical announced that it received the CE Mark for its CENTAURI Pulsed Electric Field (PEF) System and launched its commercial program. The approval...

CereVasc Announces First Patient Treated in U.S. Pilot Trial Evaluating the eShunt System

CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, announced completion of the first eShunt® procedure...

Devyser’s Quality Management System And Fetal Diagnostics Product Approved

Devyser has been certified under the new, more comprehensive IVD Regulation that came into force on May 26, 2022. The certification, issued by the...
0FansLike
0FollowersFollow
spot_img

Hot Topics